ARTICLE | Company News

Applied Pharma Research, Ferrer, tesa SE sales and marketing update

October 18, 2010 7:00 AM UTC

Applied Pharma Research and the tesa's Labtec GmbH subsidiary granted Grupo Ferrer exclusive rights to commercialize Donepezil Oral Dispersible Film to treat Alzheimer's disease in Spain, Portugal and Germany. The partners expect to submit a regulatory application in the EU next quarter. Applied Pharma Research and Labtec partnered to develop the product in 2006. Further terms were not disclosed. ...